Airway diseases
Respiratory critical care
Oral presentation
COVID-19: diagnosis and treatments
Clinical
Methods :
Epidemiology, General respiratory patient care, Public health, Cell and molecular biology, Pulmonary function testing, Pulmonary rehabilitation, Respiratory intensive care
Chairs
G. Hynes
Oxford (Oxfordshire)
(United Kingdom)
09:30
Late Breaking Abstract - INNA-051 prophylaxis enhances innate immune responses confirming accelerated viral clearnace in a human influenza challenge model.
F. Mercuri(Melbourne, Australia)
COI
1
09:35
The impact of the COVID-19 pandemic in deaths due to respiratory diseases: A comparative analysis of 2021 and 2020 vs background rates in 2019 in Spain
J. Soriano(Madrid, Spain)
COI
2
09:40
LSC - 2023 - Longitudinal proteomic profiling reveals early onset increase in collagens and (auto-)antibodies in COVID-19 patients
A. Semenova(Munich, Germany)
COI
3
09:45
Diagnosis of COVID-19 with enhanced real-time mass spectrometry breath analysis
S. Grassin Delyle(Montigny le Bretonneux, France)
COI
4
09:50
Abnormal immune response in patients with persistent lung sequelae after COVID-19
T. Cruz Santa Cruz(Barcelona, Spain)
COI
5
09:55
Plasma proteomics of critical COVID-19 patients and the effect of imatinib treatment
E. Duijvelaar(Amsterdam, Netherlands)
COI
6
10:00
Expression patterns of Interleukin-33 and its receptor ST2 in severe COVID-19
C. Lindö(Lund, Sweden)
COI
7
10:05
DIURNAL RHYTHMS IN COVID-19 VACCINE EFFICACY
G. Hazan(Dvira, Israel)
COI
8
10:10
Post-Hospitalisation COVID-19 (PHOSP-COVID): a prospective multi-centre UK cohort study
O. Elneima(Leicester, United Kingdom)
COI
9
10:15
Subtle Pulse Electro-biological Recovery Apparatus (SPERA) as anti-inflammatory treatment for COVID-19 – A Proof of Concept Study
S. Frent(Timisoara, Romania)
COI
10
10:20
Discussion and Q&A
11
OA2493
. . .
